Global Point-of-Care/Rapid Diagnostics Market Overview:
Global Point-of-Care/Rapid Diagnostics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Point-of-Care/Rapid Diagnostics Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Point-of-Care/Rapid Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Point-of-Care/Rapid Diagnostics Market:
The Point-of-Care/Rapid Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Point-of-Care/Rapid Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Point-of-Care/Rapid Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Point-of-Care/Rapid Diagnostics market has been segmented into:
OTC-based Testing
Prescription-based Testing
By Application, Point-of-Care/Rapid Diagnostics market has been segmented into:
Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Point-of-Care/Rapid Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Point-of-Care/Rapid Diagnostics market.
Top Key Players Covered in Point-of-Care/Rapid Diagnostics market are:
Abbott Laboratories
AccuBioTech Co. Ltd.
Becton
Dickinson and Company
Chembio Diagnostic Systems Inc.
Danaher Corporation
EKF Diagnostics Holdings PLC
Instrumentation Laboratory
Johnson & Johnson
Nova Biomedical Corporation
PTS Diagnostics
Quidel Corporation
Roche Diagnostics (Schweiz) AG
Sekisui Diagnostics LLC
Siemens AG
Trinity Biotech PLC
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Point-of-Care/Rapid Diagnostics Market Type
4.1 Point-of-Care/Rapid Diagnostics Market Snapshot and Growth Engine
4.2 Point-of-Care/Rapid Diagnostics Market Overview
4.3 OTC-based Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 OTC-based Testing: Geographic Segmentation Analysis
4.4 Prescription-based Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Prescription-based Testing: Geographic Segmentation Analysis
Chapter 5: Point-of-Care/Rapid Diagnostics Market Application
5.1 Point-of-Care/Rapid Diagnostics Market Snapshot and Growth Engine
5.2 Point-of-Care/Rapid Diagnostics Market Overview
5.3 Lateral Flow Assays
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Lateral Flow Assays: Geographic Segmentation Analysis
5.4 Dipsticks
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Dipsticks: Geographic Segmentation Analysis
5.5 Microfluidics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Microfluidics: Geographic Segmentation Analysis
5.6 Molecular Diagnostics
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Molecular Diagnostics: Geographic Segmentation Analysis
5.7 Immunoassays
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Immunoassays: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Point-of-Care/Rapid Diagnostics Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES; ACCUBIOTECH CO.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 LTD.; BECTON
6.4 DICKINSON AND COMPANY; CHEMBIO DIAGNOSTIC SYSTEMS
6.5 INC.; DANAHER CORPORATION; EKF DIAGNOSTICS HOLDINGS PLC; INSTRUMENTATION LABORATORY; JOHNSON & JOHNSON; NOVA BIOMEDICAL CORPORATION; PTS DIAGNOSTICS; QUIDEL CORPORATION; ROCHE DIAGNOSTICS (SCHWEIZ) AG; SEKISUI DIAGNOSTICS LLC; SIEMENS AG; TRINITY BIOTECH PLC
Chapter 7: Global Point-of-Care/Rapid Diagnostics Market By Region
7.1 Overview
7.2. North America Point-of-Care/Rapid Diagnostics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 OTC-based Testing
7.2.2.2 Prescription-based Testing
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Lateral Flow Assays
7.2.3.2 Dipsticks
7.2.3.3 Microfluidics
7.2.3.4 Molecular Diagnostics
7.2.3.5 Immunoassays
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Point-of-Care/Rapid Diagnostics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 OTC-based Testing
7.3.2.2 Prescription-based Testing
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Lateral Flow Assays
7.3.3.2 Dipsticks
7.3.3.3 Microfluidics
7.3.3.4 Molecular Diagnostics
7.3.3.5 Immunoassays
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Point-of-Care/Rapid Diagnostics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 OTC-based Testing
7.4.2.2 Prescription-based Testing
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Lateral Flow Assays
7.4.3.2 Dipsticks
7.4.3.3 Microfluidics
7.4.3.4 Molecular Diagnostics
7.4.3.5 Immunoassays
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Point-of-Care/Rapid Diagnostics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 OTC-based Testing
7.5.2.2 Prescription-based Testing
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Lateral Flow Assays
7.5.3.2 Dipsticks
7.5.3.3 Microfluidics
7.5.3.4 Molecular Diagnostics
7.5.3.5 Immunoassays
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Point-of-Care/Rapid Diagnostics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 OTC-based Testing
7.6.2.2 Prescription-based Testing
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Lateral Flow Assays
7.6.3.2 Dipsticks
7.6.3.3 Microfluidics
7.6.3.4 Molecular Diagnostics
7.6.3.5 Immunoassays
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Point-of-Care/Rapid Diagnostics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 OTC-based Testing
7.7.2.2 Prescription-based Testing
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Lateral Flow Assays
7.7.3.2 Dipsticks
7.7.3.3 Microfluidics
7.7.3.4 Molecular Diagnostics
7.7.3.5 Immunoassays
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Point-of-Care/Rapid Diagnostics Scope:
|
Report Data
|
Point-of-Care/Rapid Diagnostics Market
|
|
Point-of-Care/Rapid Diagnostics Market Size in 2025
|
USD XX million
|
|
Point-of-Care/Rapid Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Point-of-Care/Rapid Diagnostics Base Year
|
2024
|
|
Point-of-Care/Rapid Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, AccuBioTech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostic Systems Inc., Danaher Corporation, EKF Diagnostics Holdings PLC, Instrumentation Laboratory, Johnson & Johnson, Nova Biomedical Corporation, PTS Diagnostics, Quidel Corporation, Roche Diagnostics (Schweiz) AG, Sekisui Diagnostics LLC, Siemens AG, Trinity Biotech PLC.
|
|
Key Segments
|
By Type
OTC-based Testing
Prescription-based Testing
By Applications
Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays
|
